ID   NUIGi025-B
SY   ND14C9
DR   BioSamples; SAMEA6080811
DR   hPSCreg; NUIGi025-B
DR   Wikidata; Q98128188
RX   PubMed=31759289;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; 8008; NRXN1; Unexplicit; Ex1-5del; Zygosity=Heterozygous (PubMed=31759289).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_XI96 ! NUIGi025-A
SX   Male
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 6
RX   PubMed=31759289; DOI=10.1016/j.scr.2019.101653;
RA   Ding Y.-C., de la Cruz B.M., Xia Y.-W., Liu M., Lu Y., McInerney V.,
RA   Krawczyk J., Lynch S.A., Howard L., O'Brien T., Gallagher L.,
RA   Shen S.-B.;
RT   "Derivation of familial iPSC lines from three ASD patients carrying
RT   NRXN1alpha(+/-) and two controls (NUIGi022-A, NUIGi022-B; NUIGi023-A,
RT   NUIGi023-B; NUIGi025-A, NUIGi025-B; NUIGi024-A, NUIGi024-B;
RT   NUIGi026-A, NUIGi026-B).";
RL   Stem Cell Res. 41:101653-101653(2019).